EVOLUS, INC. Increase (Decrease) in Other Current Assets
EVOLUS, INC. (EOLS) reported Increase (Decrease) in Other Current Assets of $1.73 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2025-05-07
- EVOLUS, INC. increase (decrease) in other current assets for the quarter ending 2025-03-31 was $1.73M.
- EVOLUS, INC. increase (decrease) in other current assets for the quarter ending 2024-12-31 was -$1.19M, a 222.38% decline year-over-year.
- EVOLUS, INC. increase (decrease) in other current assets for the quarter ending 2024-09-30 was $416.00K.
- EVOLUS, INC. increase (decrease) in other current assets for the quarter ending 2024-06-30 was $584.00K, a 5209.09% increase year-over-year.
- EVOLUS, INC. increase (decrease) in other current assets for fiscal 2024 was -$706.00K, a 181.71% decline from fiscal 2023.
- EVOLUS, INC. increase (decrease) in other current assets for fiscal 2023 was $864.00K.
- EVOLUS, INC. increase (decrease) in other current assets for fiscal 2022 was -$4.85M, a 169.24% decline from fiscal 2021.
- EVOLUS, INC. increase (decrease) in other current assets for fiscal 2021 was $7.01M.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2025-03-31 | $1.73M 10-Q · filed 2025-05-07 | $541.00K derived: sum of 2 quarters · filed 2025-05-07 | $957.00K derived: sum of 3 quarters · filed 2025-05-07 | $1.54M derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-12-31 | -$1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$776.00K derived: sum of 2 quarters · filed 2025-03-04 | -$192.00K derived: sum of 3 quarters · filed 2025-03-04 | -$706.00K 10-K · filed 2025-03-04 |
| 2024-09-30 | $416.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.00M derived: sum of 2 quarters · filed 2024-11-06 | $486.00K 10-Q · filed 2024-11-06 | $1.46M derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-06-30 | $584.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $70.00K 10-Q · filed 2024-07-31 | $1.04M derived: sum of 3 quarters · filed 2025-05-07 | $1.01M derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-03-31 | -$514.00K 10-Q · filed 2025-05-07 | $460.00K derived: sum of 2 quarters · filed 2025-05-07 | $427.00K derived: sum of 3 quarters · filed 2025-05-07 | $438.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $974.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $941.00K derived: sum of 2 quarters · filed 2025-03-04 | $952.00K derived: sum of 3 quarters · filed 2025-03-04 | $864.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | -$33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$22.00K derived: sum of 2 quarters · filed 2024-11-06 | -$110.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$77.00K 10-Q · filed 2024-07-31 | ||
| 2023-03-31 | -$88.00K 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | -$4.85M 10-K · filed 2025-03-04 | |||
| 2021-12-31 | $7.01M 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |